Anesth Pain Med.  2024 Jul;19(3):227-232. 10.17085/apm.24027.

Does drug-induced liver injury still occur after sevoflurane anesthesia? -A case report-

• Lee MO
• Cho S
• Kim C
• Koh H

• KMID: 2563562
• DOI: http://doi.org/10.17085/apm.24027

Abstract

Background
Several factors contribute to post-anesthetic hepatic dysfunction, including a decrease in oxygen supply to the liver, direct physical compression of the liver, viral hepatitis, blood transfusions, preexisting hepatic dysfunction, and the use of hepatotoxic drugs. Diagnosing volatile anesthetic drug-induced liver injury (VA-DILI) involves excluding these causes. Case: The patient underwent total mastectomy under anesthesia using sevoflurane. He had diabetes, and no abnormal results were found on preoperative laboratory examinations, and surgery was uneventful. Abnormal laboratory findings were observed after surgery, including an aspartate aminotransferase level of 1,417 IU/L, an alanine aminotransferase level of 2,176 IU/L, and a total bilirubin level of 3.8 mg/dl. He presented with symptoms of mild icteric sclera, fatigue, and pruritus. After ruling out other causes of liver injury, we concluded that these results indicated VA-DILI.
Conclusions
VA-DILI, though rare, we should be aware of the association between the disease and the use of halogenated anesthetics.

Keyword

Hepatic failure; Drug-induced liver injury; Liver function tests; Anesthesia; Anesthetic; Sevoflurane

Reference

1. Anderson JS, Rose NR, Martin JL, Eger EI, Njoku DB. Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies. Anesth Analg. 2007; 104:1452–3.

2. Oh SK, Lim GL, Kim YS, Kim SS. Comparison of the postoperative liver function between total intravenous anesthesia and inhalation anesthesia in patients with preoperatively elevated liver transaminase levels: a retrospective cohort study. Ther Clin Risk Manag. 2020; 16:223–32.

3. Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, et al; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2014; 59:661–70.

4. Cheron C, Hoet P, Renard N, Vanderweerden G, Miscu C, Komuta M, et al. Fulminant hepatic failure in the course of an outpatient anesthetic procedure: sevoflurane among other high-risk factors. Case Rep Anesthesiol. 2020; 2020:5124098.

5. Edward JF. The hepatic effects of sevoflurane. Anesth Analg. 1995; 81(6 Suppl):S46–50.

6. Björnsson ES. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol. 2017; 52:617–62.

7. Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017; 33:158–63.

8. Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med. 2007; 46:1063–70.

9. Temiz MZ, Yuruk E, Teberik K, Akbas BK, Piroglu MD, Oztorun HS, et al. Ischemic hepatitis after percutaneous nephrolithotomy: a case report. Int J Surg Rep. 2014; 5:1258–60.

10. Lin J, Moore D, Hockey B, Lernia RD, Gorelik A, Liew D, et al. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients. Liver Int. 2014; 34:576–82.

11. Khalil S, Glorimar M, Tabrizi HK. Sevoflurane-induced hepatotoxicity? Paediatr Anaesth. 2006; 16:806; author reply 806-7.

12. Jang Y, Kim I. Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction. Pediatric Anesthesia. 2005; 15:1140–4.

13. Lee J, Kim MS, Lee HM, Lee JR, Park JH. The comparison of desflurane and sevoflurane on postoperative hepatic function of infant with biliary atresia undergoing Kasai operation. Anesth Pain Med. 2019; 14:272–9.

14. Safari S, Motavaf M, Siamdoust SAS, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J. 2014; 16:e20153.

15. Bishop B, Hannah N, Doyle A, Amico F, Hocky B, Moore D, et al. A prospective study of the incidence of drug-induced liver injury by the modern volatile anesthetics sevoflurane and desflurane. Aliment Pharmacol Ther. 2019; 49:940–51.